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Figure S1. Examples of Different Types of Gene Expression Responses in 
Two-Dimensional Concentration Gradients of TMP and SPR 
Expression level Ex is shown in color code: blue indicates down-regulation, red 
up-regulation, and white no change in gene expression (cf. Figure 3B). (A) The 
promoters hdeA and cysB both show conflicting responses, i.e. they are 
oppositely regulated in response to the individual drugs TMP and SPR. (B) The 
promoters nhaA and pykF both show consistent responses, i.e. they are up-
regulated in response to both individual drugs. (C) The promoters tolC and malZ 
show no or very weak responses to these drugs. (D) The promoters serA and 
bioB respond almost exclusively to TMP and almost exclusively to SPR, 
respectively. In these examples, the expression level in the drug combination 
mostly lies between the levels in the individual drugs as is the case for most 
promoters (see also Figure 3B). Drug concentrations are in units of the Minimal 
Inhibitory Concentration (MIC, see Table 1). 
 Figure S2. Examples of Different Types of Gene Expression Responses in 
Two-Dimensional Concentration Gradients of TET and SPR 
Expression level Ex is shown in color code (cf. Figures 3B, S1). (A) The 
promoters hdeA and brnQ both show conflicting responses. (B) The promoters 
plsB and cysB both show consistent responses. (C) The promoters minC and 
dinJ show no or very weak responses to the drugs TET and SPR alone or in 
combination. (D) The promoters ilvL and msrA respond almost exclusively to TET 
and almost exclusively to SPR, respectively. In these examples, the expression 
level in the drug combination lies between the levels in the individual drugs which 
is the case for most promoters (see also Figures 3B, S1). Drug concentrations 
are in units of the MIC (see Table 1). 
 Figure S3. Examples of Promoters that Resolve Gene Regulatory Conflicts 
by Prioritizing in the TMP-SPR Drug Combination or by Averaging in the 
TET-SPR Combination 
(A) Expression levels of promoters cysB, uspA, hdeA, wrbA, and recA in two-
dimensional drug concentration space of TMP-SPR in color code (see also 
Figure 5C). Gene expression levels along the growth rate isobole (dashed black 
line, normalized growth rate g=0.5) are shown on the right. Magenta lines: 
sigmoidal fits (see Experimental Procedures). Conflicts in gene expression are 
resolved in a prioritized response, leading to a relatively sharp transition between 
the conflicting expression levels as TMP is continuously replaced with SPR (cf. 
Figure 1B). (B) As A, but for different example genes ptsG, brnQ, htpG, amyA, 
and glgS, which show conflicts in the two-dimensional drug concentration space 
of TET-SPR (see also Figure 5D). Magenta lines: linear fits (see Experimental 
Procedures).Conflicts in gene expression are smoothly averaged, leading to a 
linear transition between the conflicting expression levels (cf. Figure 1B). Error-
bars correspond to two standard deviations estimated from replicate 
measurements done on different days (Experimental Procedures). 
 Figure S4. Examples of Promoters Showing a Biased Prioritized Response 
to the TMP-SPR Drug Combination 
Expression levels of promoters pheL, serA, and hipB in two-dimensional drug 
concentration space of TMP-SPR in color code. Gene expression levels along 
the growth rate isobole (dashed black line, normalized growth rate g=0.5) are 
shown on the right. Magenta lines: sigmoidal fits (see Experimental Procedures). 
In the TMP-SPR drug combination, these promoters show a biased prioritized 
response (cf. Figure 1B), i.e. the transition point x0 of the prioritized response 
(inset Figure 5E) is not located at effective drug fraction 0.5 where both drugs 
contribute equally to growth inhibition. The promoters shown here are all 
dominated by TMP, i.e. the transition point is located near the pure SPR drug 
environment. Error-bars correspond to two standard deviations estimated from 
replicate measurements done on different days (Experimental Procedures). 
 Figure S5. Examples of Promoters Showing Combination-Specific 
Responses to Antibiotic Combinations 
(A) Expression levels of promoter glyA in two-dimensional drug concentration 
space of TMP-SPR in color code. The glyA promoter, which has a large score for 
the third principal component (Figure 6A), is up-regulated in response to TMP 
and SPR individually and up-regulated to much higher levels in the combination. 
Similar to slp (Figure 6D), glyA expression is regulated by multiple transcription 
factors (PurR and MetR). (B) The uspA promoter shows a similar drug 
combination-specific response to the TET-SPR combination. However, uspA is 
the only promoter in our data set (Table S1) showing this behavior for the TET-
SPR combination. Similar to glyA (A) and slp (Figure 6D), uspA is known to be 
regulated by two different transcription factors (IHF and FadR).  
 
 
Table S1. Genome-Wide Sample of 103 Promoters Used in This Study 
Promoter Description 
amyA cytoplasmic alpha-amylase 
arcA* response regulator (OmpR family), in two-component regulatory system with ArcB (or 
CpxA), regulates genes in aerobic respiration (1st module) 
aroH 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase (DAHP synthetase), 
tryptophan repressible 
aroL♦ shikimate kinase II 
atpI membrane-bound ATP synthase subunit, F1-F0-type proton-ATPase 
bioB biotin synthetase (2nd module) 
bolA activator of morphogenic pathway (BolA family), important in general stress response 
brnQ LIVCS family, branched chain amino acid transporter system II (LIV-II) 
clpP proteolytic subunit of clpA-clpP ATP-dependent serine protease, heat shock protein 
F21.5 
crp transcriptional regulator, catabolite activator protein (CAP), cyclic AMP receptor 
protein (CAMP-binding family), interacts with RNAP 
cspA*# major cold shock protein 7.4, transcription antiterminator of hns, 
cspD similar to CspA but not cold shock induced, nucleic acid-binding domain 
cyoA cytochrome o ubiquinol oxidase subunit II 
cysB transcriptional regulator for biosynthesis of L-cysteine (LysR familiy) (1st module) 
cysP ABC superfamily (peri_bind)  thiosulfate transport protein 
dacA D-alanyl-D-alanine carboxypeptidase, penicillin-binding protein 5 (1st module) 
dinJ damage-inducible protein J 
dinP♦ DNA polymerase IV, devoid of proofreading, damage-inducible protein P (1st module) 
dnaK* chaperone Hsp70 in DNA biosynthesis/cell division (1st module) 
dnaX DNA polymerase III, tau and gamma subunits; DNA elongation factor III (1st module) 
dps# stress response DNA-binding protein; starvation induced resistance to H2O2, ferritin-
like 
emrE* DLP12 prophage; MFP family auxillary multidrug transport protein, methylviologen 
and ethidium resistance 
evgA response regulator (activator)  in two-component regulatory system with EvgS, 
regulates multidrug resistance  (LuxR/UhpA family) 
fecI sigma (19) factor of RNA polymerase, affected by  FecR and outer membrane 
receptor FecA (TetR/ArcR family) 
fepA outer membrane porin, receptor for ferric enterobactin (enterochelin) and colicins B 
and D (1st module) 
fliA*♦ sigma F (sigma 28) factor of RNA polymerase, transcription of late flagellar genes 
(class 3a and 3b operons) 
folA dihydrofolate reductase type I; trimethoprim resistance 
fumC*♦ fumarase C (fumarate hydratase Class II) (2nd module) 
galE UDP-galactose 4-epimerase (1st module) 
glgS glycogen biosynthesis, rpoS dependent 
glyA# serine hydroxymethyltransferase (2nd module) 
gnd gluconate-6-phosphate dehydrogenase, decarboxylating (1st module) 
hdeA HdeA dimer, inactive form of acid-resistance protein 
hipB transcriptional repressor which interacts with HipA 
hisL his operon leader peptide 
hisS histidine tRNA synthetase (operon includes yfgL, see D. Kahne, Science, 2001) 
htpG chaperone Hsp90, heat shock protein C 62.5 
htpX heat shock protein, integral membrane protein 
icdA isocitrate dehydrogenase in e14 prophage, specific for NADP+ (2nd module) 
ileX# isoleucine tRNA 2 
ilvL ilvGEDA operon leader peptide 
inaA♦ pH inducible protein involved in stress response, protein kinase-like 
lexA transcriptional repressor for SOS response (signal peptidase of LexA family) 
lpdA dihydrolipoamide dehydrogenase, FAD/NAD(P)-binding ; component of 2-
oxodehydrogenase and pyruvate complexes; L protein of glycine cleavage complex 
second part (2nd module) 
malZ♦ maltodextrin glucosidase (2nd module) 
marR*♦ transcriptional repressor for antibiotic resistance and oxidative stress 
minC cell division inhibitor; activated MinC inhibits FtsZ ring formation 
mscL♦ mechanosensitive channel 
msrA peptide methionine sulfoxide reductase 
nfo* endonuclease IV 
nhaA* NhaA family of transport protein, Na+/H antiporter (1st module) 
nuoA* NADH dehydrogenase I chain A 
osmC resistance protein, osmotically inducible 
oxyR* transcriptional regulator of oxidative stress, regulates intracellular hydrogen peroxide 
(LysR family) 
pheL leader peptide of chorismate mutase-P-prephenate dehydratase 
plsB glycerolphosphate acyltransferase (2nd module) 
polB♦ DNA polymerase II and and 3' --> 5' exonuclease 
poxB*♦ pyruvate dehydrogenase/oxidase  FAD and thiamine PPi binding, cytoplasmic in 
absence of cofactors (1st module) 
ptsG multimodular PtsG: PTS family enzyme IIC, glucose-specific (1st module) 
pykF pyruvate kinase I (formerly F), fructose stimulated (2nd module) 
recA# DNA strand exchange and recombination protein with proteiase and nuclease activity 
(1st module) 
recN♦ protein used in recombination and DNA repair (2nd module) 
rmf# ribosome modulation factor  (involved in dimerization of 70S ribosomes) 
rob (activator of acrAB operon) transcriptional activator for resistance to antibiotics, 
organic solvents and heavy metals (AraC/XylS family) (right origin binding protein) 
(1st module) 
rpiA ribosephosphate isomerase, constitutive 
rplN 50S ribosomal subunit protein L14 
rplY 50S ribosomal subunit protein L25 
rpmB 50S ribosomal subunit protein L28 
rpmE# 50S ribosomal subunit protein L31 
rpoD*♦ sigma D (sigma 70) factor of RNA polymerase , major sigma factor during exponential 
growth (2nd module) 
rpoH sigma H (sigma 32) factor of RNA polymerase; transcription of heat shock proteins 
induced by cytoplasmic stress 
rpoS*♦ sigma S (sigma 38) factor of RNA polymerase, major sigmafactor during stationary 
phase 
rpsA 30S ribosomal subunit protein S1 (3rd module) 
rpsB 30S ribosomal subunit protein S2 
rpsT* 30S ribosomal subunit protein S20 
rpsU 30S ribosomal subunit protein S21 
rrsA# 16S rRNA 
rsd regulator of sigma D, has  binding activity to the major sigma subunit of RNAP 
sbmC♦ DNA gyrase inhibitor 
sdhC succinate dehydrogenase , cytochrome b556 
serA D-3-phosphoglycerate dehydrogenase 
serC 3-phosphoserine aminotransferase / phosphohydroxythreonine transaminase 
serU serine tRNA 2 
slp# outer membrane protein, induced after carbon starvation 
smpA small membrane protein A 
sodA* superoxide dismutase, manganese 
sspA stringent starvation protein A, regulator of transcription 
thiC 5'-phosphoryl-5-aminoimidazole = 4-amino-5-hydroxymethyl-2-methylpyrimidine-P 
tolA*♦ tol protein required for outer membrane integrity, uptake of group A colicins, C-
terminal is coreceptor with F pilus for filamentous phages, role in translocation of 
filamenous phage DNA to cytoplasm (1st module) 
tolC* outer membrane channel; specific tolerance to colicin E1; segregation of daughter 
chromosomes, role in organic solvent tolerance 
trpR* transcriptional repressor for tryptophan biosynthesis (TrpR family) 
umuD*♦ component of DNA polymerase V , signal peptidase with UmuC 
uspA universal stress protein A 
uvrA♦ UvrA with UvrBC is a DNA excision repair enzyme (2nd module) 
uvrD* DNA-dependent ATPase I and helicase II (1st module) 
wrbA# flavodoxin-like protein, trp repressor binding protein 
yaeL*♦ putative protease 
ydeB* marC, inner membrane protein involved in multiple antibiotic resistance 
ydhE* NorE multidrug efflux MATE transporter (1st module) 
 
yebG*♦ DNA damage-inducible gene in SOS regulon, dependent on cyclic AMP and H-NS 
yebQ* putative MFS family transport protein (1st module) 
yojH  
yojI putative ABC superfamily (atp module of atp&membrane) transport protein (2nd 
module) 
♦ Promoters with low GFP signal. These were excluded from further analysis.  
* Expression of these promoters was measured only in TMP-SPR to test if the PCA results 
change when the set of promoters is enlarged. All results, in particular the PCA results in Figures 
4-6, are independent of whether these promoters are included in the analysis or not. To compare 
PCA results of the TMP-SPR and TET-SPR data sets, these promoters were excluded from the 
analysis, so that the exact same set of promoters is used for both drug pairs.  
# These promoters were integrated in the chromosome for the single-cell experiment (Figure 7). 
 
 
